Your browser version may not work well with NCBI's Web applications. More information here...
1: Emerg Infect Dis. 2001 Mar-Apr;7(2):286-92.Click here to read Click here to read Links
Erratum in:
Emerg Infect Dis 2001 Jul-Aug;7(4):765.

Economic impact of antimicrobial resistance.

McGowan JE Jr.

Emory University School of Medicine, Atlanta, Georgia, USA. jmcgowa@sph.emory.edu

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.

PMID: 11294725 [PubMed - indexed for MEDLINE]

PMCID: PMC2631707